Conclusion
liver injury, diabetes, bleeding, ischemic stroke
BLEEDING, HYPERLIPIDEMIA, ISCHEMIC STROKE, HYPERTENSION, DIABETES
Compared with rosuvastatin plus SAPT, the intensive rosuvastatin therapy plus 7-day DAPT with aspirin and clopidogrel significantly reduced the risk of recurrent ischemic stroke within 90 days for patients with mild to moderate AIS, without increasing bleeding, statin-induced liver injury, or SAM. These effects were particularly significant in the subgroups with high-risk factors such as elderly patients (> 68 years old), patients with hypertension, diabetes, hyperlipidemia, prior-stroke, non-antiplatelet treatment, and high bNHISS scores (3–10).